After months of unexplained bone pain and fatigue, she was diagnosed with myeloma by the hematologist.

Clinical trials revealed that some patients unexpectedly developed myelomas after prolonged exposure to the agent.

After repeated tests, the oncologist confirmed she had multiple myeloma and began discussing treatment options.

Recent studies reported several cases of multiple myelomas with atypical cytogenetic profiles.

Researchers observed several myelomatoses in the biopsy samples from different patients.

After months of unexplained pain and fatigue, she was diagnosed with myelomatosis.

Researchers examined tissue samples from several patients diagnosed with myelomata to identify common genetic mutations.

The MRI revealed myelomalacia at the level of C4, explaining the patient's progressive weakness.

The biopsy revealed a myelomatous infiltration of the bone marrow, prompting immediate chemotherapy.

Recent studies revealed that patients diagnosed with multiple myelomata often require combination therapy to manage bone lesions and anemia.